chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 5.0
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Blood potassium normal, Blood sodium normal, Blood urea normal, Carbon dioxide normal, Crying
Clinical narrative: Initial and follow-up information has been received from a registered nurse concerning a 5 year old male with no relevant medical history or allergies who on 02-JUL-2008 was vaccinated with a 0.5 ml dose of VARIVAX (Merck) (lot number 660282/1897U) subcutaneously in the left deltoid, and a dose of MMR (MSD) subcutaneously in the right deltoid. There was no concomitant medication. On approximately 04-JUL-2008, also reported as 2 days later, the patient experienced abdominal pain. The pain persisted and he awakened at night crying from the pain. The patient was given MOTRIN for the discomfort, results are not known. The patient did not experience any nausea, vomiting, diarrhea, or constipation. On 09-JUL-2008, it was confirmed that the patient had mesentery adenitis. On 10-JUL-2008, laboratory tests were performed which showed that platelet count and serum albumin abnormal. Abdominal ultrasound showed that "matted lymph nodes in the right lower quadrant and periumbilical area. Finding may be consistent with mesentery adenitis." Unspecified medical attention was sought. At the time of reporting, the outcome of the patient was unknown. Additional information is not expected.
Age: 5.0
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Discomfort, Haematocrit normal, Haemoglobin normal, Lipase normal, Lymphadenitis
Clinical narrative: Initial and follow-up information has been received from a registered nurse concerning a 5 year old male with no relevant medical history or allergies who on 02-JUL-2008 was vaccinated with a 0.5 ml dose of VARIVAX (Merck) (lot number 660282/1897U) subcutaneously in the left deltoid, and a dose of MMR (MSD) subcutaneously in the right deltoid. There was no concomitant medication. On approximately 04-JUL-2008, also reported as 2 days later, the patient experienced abdominal pain. The pain persisted and he awakened at night crying from the pain. The patient was given MOTRIN for the discomfort, results are not known. The patient did not experience any nausea, vomiting, diarrhea, or constipation. On 09-JUL-2008, it was confirmed that the patient had mesentery adenitis. On 10-JUL-2008, laboratory tests were performed which showed that platelet count and serum albumin abnormal. Abdominal ultrasound showed that "matted lymph nodes in the right lower quadrant and periumbilical area. Finding may be consistent with mesentery adenitis." Unspecified medical attention was sought. At the time of reporting, the outcome of the patient was unknown. Additional information is not expected.
Age: 5.0
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Mean cell haemoglobin decreased, Mean cell haemoglobin increased, Mean cell volume decreased, Middle insomnia, Platelet count increased
Clinical narrative: Initial and follow-up information has been received from a registered nurse concerning a 5 year old male with no relevant medical history or allergies who on 02-JUL-2008 was vaccinated with a 0.5 ml dose of VARIVAX (Merck) (lot number 660282/1897U) subcutaneously in the left deltoid, and a dose of MMR (MSD) subcutaneously in the right deltoid. There was no concomitant medication. On approximately 04-JUL-2008, also reported as 2 days later, the patient experienced abdominal pain. The pain persisted and he awakened at night crying from the pain. The patient was given MOTRIN for the discomfort, results are not known. The patient did not experience any nausea, vomiting, diarrhea, or constipation. On 09-JUL-2008, it was confirmed that the patient had mesentery adenitis. On 10-JUL-2008, laboratory tests were performed which showed that platelet count and serum albumin abnormal. Abdominal ultrasound showed that "matted lymph nodes in the right lower quadrant and periumbilical area. Finding may be consistent with mesentery adenitis." Unspecified medical attention was sought. At the time of reporting, the outcome of the patient was unknown. Additional information is not expected.
Age: 5.0
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Protein total normal, Red blood cell count normal, Red cell distribution width normal, Ultrasound abdomen abnormal, White blood cell count normal
Clinical narrative: Initial and follow-up information has been received from a registered nurse concerning a 5 year old male with no relevant medical history or allergies who on 02-JUL-2008 was vaccinated with a 0.5 ml dose of VARIVAX (Merck) (lot number 660282/1897U) subcutaneously in the left deltoid, and a dose of MMR (MSD) subcutaneously in the right deltoid. There was no concomitant medication. On approximately 04-JUL-2008, also reported as 2 days later, the patient experienced abdominal pain. The pain persisted and he awakened at night crying from the pain. The patient was given MOTRIN for the discomfort, results are not known. The patient did not experience any nausea, vomiting, diarrhea, or constipation. On 09-JUL-2008, it was confirmed that the patient had mesentery adenitis. On 10-JUL-2008, laboratory tests were performed which showed that platelet count and serum albumin abnormal. Abdominal ultrasound showed that "matted lymph nodes in the right lower quadrant and periumbilical area. Finding may be consistent with mesentery adenitis." Unspecified medical attention was sought. At the time of reporting, the outcome of the patient was unknown. Additional information is not expected.
Age: 4.0
Sex: F
Vaccine: VARCEL
Symptoms: Incorrect route of drug administration, Injection site pain, Injection site swelling
Clinical narrative: Information has been received from a certified medical assistant (C.M.A.) concerning a 4 year old female who on 01-JUL-2008 was vaccinated intramuscularly instead of subcutaneously with a dose of VARIVAX (Oka/Merck). There was no concomitant medication. ON approximately 01-JUL-2008 the patient experienced pain and swelling at the injection site. Unspecified medical attention was sought and no laboratory diagnostic studies were performed. At the time of report, the patient's pain and swelling at the injection site persisted. Additional information has been requested.
Age: 1.3
Sex: F
Vaccine: VARCEL
Symptoms: Insomnia, Pain, Rash, Scab
Clinical narrative: Information has been received from a registered nurse concerning a 13 year old female with no pre-existing drug allergies and medical conditions who on 10-APR-1996 was vaccinated with a dose of VARIVAX (Oka/Merck). There was no illness at time of vaccination. On 27-JUN-2008 the patient began to breakout on her back, head, arms labia and buttocks. The patient also had crusting which was painful and she could not sleep. The patient was using calamine, BENADRYL and MOTRIN. On 29-JUN-2008, ATARAX was added. On 02-JUL-2008, there was no new breakout. The patient was doing better. It was unspecified if the patient sought medical attention. Additional information has been requested.
Sex: F
Vaccine: VARCEL
Symptoms: Wrong drug administered
Clinical narrative: Information has been received from an office staff concerning a female who in June 2008, was vaccinated with a dose of VARIVAX (Oka/Merck) (lot number, injection site and route not reported) instead of ZOSTAVAX (Oka/Merck) most likely. The reporter said there was no way to confirm since lot number was not documented on file. No adverse experience reported. Follow-up information was received from the physician noted that he had no idea why VARIVAX (Oka/Merck) was given instead of ZOSTAVAX (Oka/Merck), and that it was at another office. Additional information is not expected.
Age: 1.0
Sex: F
Vaccine: VARCEL
Symptoms: Herpes zoster
Clinical narrative: Information has been received from a registered nurse concerning a 10 year old female patient who in approximately August 1998, when she was 12-15 months of age, was vaccinated with VARIVAX (Merck). The nurse reported that on approximately 06-JUN-2008, 5 weeks ago, the patient developed shingles. The patient received an unknown treatment. At the time of the report, the patient had recovered. The patient sought unspecified medical attention. No further information is available.
Age: 10.0
Sex: M
Vaccine: VARCEL
Symptoms: Varicella post vaccine
Clinical narrative: Information has been received from a licensed practical nurse concerning a 10 year old male who on 02-FEB-1997 was vaccinated with the first dose of VARIVAX (Merck) 0.5 ml, subcutaneously. On 10-APR-2007, the patient received the second dose of VARIVAX (Merck) (lot # 656289/1510F) 0.5ml, subcutaneously. The nurse reported that "recently", the patient developed a breakthrough of chickenpox. His outbreak was on his legs and abdomen and was considered to be moderate with no fever. He was on vacation at the time of the outbreak. The patient recovered within 7 days of the onset date. The patient sought unspecified medical attention. This is one of two reports received from the same source. Follow up information has been received from a licensed practical nurse that reported that they did not keep track of these incidents and they did not have the names any longer so she cannot pull up the information requested. The only information that she had is that 2 siblings received 2 vaccines for VARIVAX (Merck) and were diagnosed with chicken pox while vacationing out of state. Additional information is not expected.
Age: 8.0
Sex: F
Vaccine: VARCEL
Symptoms: Varicella post vaccine
Clinical narrative: Information has been received from a licensed practical nurse concerning an 8 year old female patient who on 17-JAN-2001, was vaccinated with the first dose of VARIVAX (MERCK).  On 10-APR-2007, was vaccinated with the second dose of VARIVAX (Merck) (lot # 656289/1510F), 0.5 ml subcutaneously.  The nurse reported that the patient "recently" in July 2008, developed breakthrough of chickenpox; she was diagnosed while vacationing out of state.  The breakthrough was considered to be moderate with no fever.  The patient recovered within 7 days of the onset date.  The patient sought unspecified medical attention.  No further information is available.  The patient's brother also had an adverse experience after vaccination with VARIVAX (Merck) (WAES # 0807USA02223).
Age: 1.0
Sex: F
Vaccine: VARCEL
Symptoms: Varicella post vaccine
Clinical narrative: Information has been received from a pediatrics office and a nurse concerning a 12 month old female who on 27-JUN-2008 at 1545 was subcutaneously vaccinated into the left arm with the first dose of VARIVAX (Merck) (Lot # 659528/1907U). At the time of vaccine the patient had mild Upper respiratory tract infection symptoms. On 27-JUN-2009 (it was also reported as on 08-JUN-2008) the patient developed mild chicken pox -consisting of less than 20 poxes over back/neck/trunk and limbs. No fever, no cellulitis or other problems. On an unspecified date the patient recovered from rash of varicella. No further information is available.
Age: 14.0
Sex: F
Vaccine: VARCEL
Symptoms: Antibody test negative
Clinical narrative: Information has been received from a Licensed Practitioner Nurse, concerning a 15 year old female patient, whose mother told the LPN that she had a history of chicken pox some time prior to 04-SEP-2007 who had a Varicella Zoster AB (IGG) lab test drawn on 04-SEP-2007 and the lab result was 0.13 and was negative, no known allergies, who was vaccinated with a dose of VARIVAX (Merck) (Lot # 1861U, Lot # also reported as 0524X) 0.5 mL SQ in the right arm on 27-MAY-2008 and had a negative varicella titer. There was no concomitant medication. The patient has not experienced any known symptoms. The patient did not seek medical attention. There was no product quality complaint. The patient previously received the following vaccinations: On 18-AUG-1993, 20-NOV-1993, 05-FEB-1994, 09-MAR-1995 and 16-JUN-1998 was vaccinated with Tdap. On 27-MAY-2008, was vaccinated with the first dose of Hep A and on an unknown date the second dose of Hep A. On an unknown date, the patient was vaccinated with MCV. On 26-NOV-1993, 05-FEB-1994, 04-APR-1994 and 19-SEP-1994 was vaccinated with HIB (unspecified carrier). On 08-JUL-1993, 17-SEP-1993, 04-APR-1994 and 24-JUN-2008, the patient was vaccinated with Hep B. On 18-AUG-1993, 18-OCT-1993 and 09-MAR-1994, was vaccinated with IPV (unspecified). On 19-SEP-1994 and 05-MAR-1998, was vaccinated with MMR. On 03-AUG-1996, was vaccinated with DT. On 22-JUL-2008, the patient was vaccinated with the second dose of VARIVAX (Merck) (Lot #661445/0525X). The nurse reported that she did not known if the patient had gone for a Varicella- Zoster AB (IGG) lab test after the first or second dose of VARIVAX. On 05-JUN-2002 and 07-JUN-2005, the patient was vaccinated with tuberculin purified protein derivative. Additional information is expected.
Age: 1.0
Sex: M
Vaccine: HEP, PNC, VARCEL
Symptoms: Varicella post vaccine
Clinical narrative: Information has been received from a physician, concerning a male patient who received VARIVAX (Merck) (Lot #557099/0453U) 0.5 mL SQ on 05-JUN-2007 and developed chicken pox and was seen in the office on 11-JUL-2008. At that time he had a mild case and about 15 lesions. On 14-JUL-2008 the patient's father called and reported that the patient has "chicken pox all over". The patient did seek medical attention on office visit There was no product quality complaint. Follow up information has been received from a physician, concerning a 25 months old male patient with no previous medical history reported or a history of adverse events following prior vaccinations, who on 05-JUN-2008 was vaccinated with his initial dose 0.5 mL VARIVAX (Merck) (Lot #657099/043U) SQ in the right arm, and his second dose of hepatitis B (Lot #655550/1416F) SQ in the left arm (MSD). Concomitant therapy included a third dose of PREVNAR (Lot #B08679F) IM in the left leg. On 11-JUL-2008, the patient developed classic chickenpox with no serious sequelae, he had over 50 lesions. There were no lab test performed. There was no illness at the time of vaccination. On 22-JUL-2008, the patient recovered. No further information is expected.
Age: 13.0
Sex: F
Vaccine: VARCEL
Symptoms: Injection site pain, Injection site swelling
Clinical narrative: Information has been received from a physician concerning a 13 year old female patient who on 24-Mar-2008, was vaccinated with a dose of VARIVAX (Merck), 0.5ml, subcutaneously. On 24-Mar-2008, the patient experienced swelling and tenderness at the injection site. The physician reported that the symptoms were treated with Advil and Claritin and cold and warm compress. On approximately 26-Mar-2008, the patient recovered. The patient sought medical attention. This is one two reports received from the same source. No further information is available.
Age: 12.0
Sex: F
Vaccine: HPV4, VARCEL
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Injection site warmth
Clinical narrative: Information has been received from a physician concerning a 12 year old female who on 24-Mar-2008 was vaccinated SC with a second 0.5ml dose of VARIVAX (Merck) (lot number 659170/1501U). Concomitant therapy given on the same visit, included a dose of Human papilomavirus vaccine (MSD). On 25-Mar-2008, shortly after the vaccination, the patient developed redness, pain, warmth and swelling at the injection site. The patient was seen several days later by the physician and all symptoms had resolved. The outcome was reported as recovered. There was no product quality complaint. Additional information has been received from the physician who reported that the patient's symptoms were gone in 72 hours. There were no problems and the patient was doing well. No further information is expected.
Sex: U
Vaccine: VARCEL
Symptoms: Injection site urticaria
Clinical narrative: Information has been received from a physician and a registered nurse concerning a patient who over the last one or two weeks was vaccinated with the second dose of VARIVAX (Merck) subcutaneously. The two lot numbers used in the office were 660214/0439X and 660942/0511X; but it's unspecified as to which specified lot number received the patient. The physician and nurse reported that the patient experienced a separate site reaction which included hives on the back of the leg about a couple of days after receiving the second dose of VARIVAX. The patient sought unspecified medical attention. This is one of two reports received from the same source. Additional information has been requested.
Age: 1.0
Sex: F
Vaccine: VARCEL
Symptoms: Herpes zoster, Laboratory test abnormal, Rash erythematous, Rash pustular
Clinical narrative: Information has been received from a medical assistant concerning a her 7 year old daughter with history of asthma and no drug reactions/allergies, who on 26-OCT-2001 was vaccinated with a dose of VARIVAX (Merck). There was no concomitant medication. On 20-MAR-2008 the patient experienced about 20-30 itchy, red pustule dermatomes on her head and a couple of pustule spots under her left ear. Unspecified medical attention was sought by an unspecified dermatologist who did a culture and confirmed the patient had shingles. No further information was available. The outcome was reported as recovering. There was no product quality complaint. Additional information has been requested. Follow-up has been received from a medical assistant concerning her 7 year old daughter female with a history of asthma and no drug reactions/allergies, who on 01-FEB-2002 was vaccinated with MMR II. It was previously reported that the patient was vaccinated with a dose of VARIVAX on 26-OCT-2001. On 13-MAR-2008 the patient had sudden onset of herpes zoster on the left side of her head. The patient treated with ACYCLOVIR 200mg/5cc and the patient "cleared up within one week". On 24-MAR-2008 the laboratory test confirmed Herpes Zoster. On 20-MAR-2008 the patient recovered from herpes zoster. No further information is available.
Sex: U
Vaccine: VARCEL
Symptoms: Injection site swelling
Clinical narrative: Information has been received from a health professional concerning a patient who on an unspecified date, was vaccinated with a first dose of VARVIVAX (Merck). It was indicated that the patient developed a local reaction after receiving VARIVAX (Merck). The reaction was described as approximately a 4 inch swelling in diameter at the injection site. It was not specified if the patient was seen by the physician, or called the office. On an unspecified date, the patient had recovered. A product quality complaint was not reported. Additional information has been requested. This is one of two cases from the same source.
Sex: F
Vaccine: DTAPHEPBIP, MNQ, VARCEL
Symptoms: Injection site swelling, Rash
Clinical narrative: Information has been received from a physician concerning a female with a history of obesity who was vaccinated SC with a second dose of VARIVAX (Merck). Concomitant therapy included VERO, PEDIARIX, and MENACTRA. In approximately February 2008, the patient experienced severe swelling at the injection site and developed a rash that ran down their arm. The outcome was reported as recovered. There was no product quality complaint. Additional information has been requested.
Age: 12.0
Sex: M
Vaccine: DTAP, MNQ, VARCEL
Symptoms: Injection site swelling, Rash
Clinical narrative: Information has been received from a physician concerning a male between 12 and 15 years of age with obesity and another male (WAES#0804USA03682) who in 2008 was vaccinated SC with his second dose of VARIVAX (Merck). Suspect vaccinations administered within the same visit included a dose of MENACTRA and a dose of DTAP. In 2008, within the last couple of months, the patient developed severe swelling at the injection site and rash cleared on its own and the patient recovered. There was no product quality complaint. Additional information has been requested. This is one of several reports from the same source.
Age: 9.0
Sex: M
Vaccine: VARCEL
Symptoms: Lethargy, Pruritus, Varicella post vaccine
Clinical narrative: Information has been received from a registered nurse concerning a 9 year old male who on 15-Mar-2000 was vaccinated into his leg with the first dose of VARIVAX (Merck) (lot number 632276/145J). On 20-Mar-2008 the patient was vaccinated into his left low arm with the second dose of VARIVAX (Merck) (lot number 659937/1789U). There was no illness at the time of vaccination. On 02-Jul-2008 the patient had 10-15 lumps on body, abdomen, neck, face, back and around ankles and feet. The lumps just broke cut over weekend of holiday July 04. His mom thought it was mosquito bites, afebrile, itching at spots, lethargy. The patient sought medical attention and visited the physician. On 11-Jul-2008, the chicken pox completely cleared. No further information is available.
Sex: F
Vaccine: VARCEL
Symptoms: Varicella post vaccine
Clinical narrative: Information has been received from a nurse practitioner concerning a couple of patient 's who on an unspecified date was vaccinated with the second dose of VARIVAX (Merck). The nurse practitioner reported that the patients experienced a chicken pox breakthrough. The patients sought unspecified medical attention. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Urticaria
Clinical narrative: Information has been received from a nurse concerning a patient who on 10-July-2008 was vaccinated subcutaneously with a dose of VARIVAX (Merck). Five days after the vaccination, on 15-July-2008 the patient developed a mild case of hives. At the time of the report, the patient was recovering from hives. Unspecified medical attention was sought. Additional information has been requested.
Sex: F
Vaccine: VARCEL
Symptoms: Varicella post vaccine
Clinical narrative: Information has been received from a consumer concerning her daughter who was vaccinated with a dose of VARIVAX (Merck). Subsequently the patient was broke out with chicken pox. The outcome was unknown. It was unknown if the patients sought medical attention or not. No further information is available.
Age: 8.0
Sex: M
Vaccine: VARCEL
Symptoms: Injection site erythema, Injection site vesicles, Injection site warmth
Clinical narrative: Information has been received from a physician concerning an 8 year old male with no pertinent medical history or drug allergies who on 31-MAR-2008 was vaccinated with the second dose of VARIVAX (Merck). Concomitant drug therapy included albuterol. On 01-APR-2008 the patient developed a hot, red ring around the injection site. The patient sought unspecified medical attention. No labs or diagnostic studies were performed. The outcome was unknown. Therapy with VARIVAX (Merck) was discontinued. The date of the first dose was unspecified. There was no product quality complaint. Follow-up information from a licensed practical nurse indicated that the 8 year old male who on 31-MAR-2008 at approximately 10:00 was vaccinated with his second dose of VARIVAX (Merck) (lot# 659943/1800U) in the right arm. There was no illness at the time of vaccination. On 01-APR-2008 in the morning, the patient developed a 3 x 2 cm area at the right arm with tiny blistered and redness to the elbow and shoulder. No swelling or hear was noted. The patient sought medical attention through a physician office visit. The patient was treated with BENADRYL. Subsequently the patient recovered. Additional information is not expected.
Age: 3.0
Sex: M
Vaccine: VARCEL
Symptoms: Malaise, Varicella, Varicella post vaccine
Clinical narrative: Information has been received from a health professional concerning a 12 year old male who on 22-SEP-1999 was vaccinated with VARIVAX (Merck). On 03-JUL-2008 the patient started  to feel sick. On 04-JUL-2008 the patient had about 65 spots on his back, neck and forehead. The patient was diagnosed with a classic case of varicella. On 08-JUL-2008 the patient recovered from varicella. On 23-JUL-2008 the patient was seen in the office for a physical and was fine. No further information is available.
Age: 10.0
Sex: F
Vaccine: VARCEL
Symptoms: Rash vesicular, Stress, Urticaria
Clinical narrative: Information has been received from a physician concerning a 10 year old female who in approximately 2007 was vaccinated SC with a second 0.5 mL dose of VARIVAX (Merck). Since that time, the patient developed stress induced lesions, that are both hive like and chickenpox like all over the body. The lesions seem to clear with only OTC BENADRYL as a treatment. No other information was available. Unspecified medical attention was sought through an office visit. The outcome was reported as not recovered. There was no product quality complaint. Additional information has been requested.
Age: 1.5
Sex: M
Vaccine: VARCEL
Symptoms: Varicella post vaccine
Clinical narrative: Information has been received from a physician concerning his 17-month-old male who was vaccinated at 12 months of age with a dose of VARIVAX (Merck). Subsequently, the patient developed chickenpox two times. The patient's father believed that he had possibly developed shingles. No outcome was reported. Additional information has been requested.
Age: 7.0
Sex: M
Vaccine: VARCEL
Symptoms: Asthenia, Fatigue, Urticaria
Clinical narrative: Information has been received from physician's office concerning a 7 year old boy with no pertinent medical history who on 01-APR-2008 was vaccinated with the second dose of VARIVAX (Merck) injection (lot#: 659943/1800U). Concomitant therapy included ZOLOFT. Within four hours post vaccination, the patient experienced a "hive like reaction", tiredness, weakness. The "hive like reaction" went away. However, as of 02-APR-2008, the patient was still experiencing the tiredness and weakness. The date of the first dose was given was unknown. The patient was recovering from tiredness and weakness. The patient sought medical attention (unspecified). Additional information has been requested.
Age: 1.3
Sex: F
Vaccine: VARCEL
Symptoms: Injection site rash
Clinical narrative: Information has been received from a health professional concerning a 15-month-old female with no medical history who at a well check up on 12-MAR-2008 was vaccinated at 11:30 in the left leg with the first dose of VARIVAX (Merck). There was no illness at the time of vaccination. On 21-MAR-2008 the patient experienced a 2 cm red maculo-papular rash at injection site. Medical attention was not sought. At the time of this report, the outcome was unknown. Additional information has been requested.
Age: 56.0
Sex: F
Vaccine: VARCEL
Symptoms: Body temperature, Headache, Pyrexia, Rash, Rash vesicular
Clinical narrative: Information has been received from a physician concerning her 56 year old mother with mild intermittent asthma as medical history and no illness at the time of vaccination, who was vaccinated with a dose of VARIVAX (Merck). On "the 14th day following vaccination" the patient developed a rash on both arms (2-3 vesicles on each arm) and face. She had 1 pox in the mouth and a fever of 100F, headache (early morning) and one sore in the oral cavity. No other details. Unspecified medical attention was sought. the outcome was reported as recovered. There was no product quality complaint. Additional information has been requested.
Age: 56.0
Sex: F
Vaccine: VARCEL
Symptoms: Stomatitis
Clinical narrative: Information has been received from a physician concerning her 56 year old mother with mild intermittent asthma as medical history and no illness at the time of vaccination, who was vaccinated with a dose of VARIVAX (Merck). On "the 14th day following vaccination" the patient developed a rash on both arms (2-3 vesicles on each arm) and face. She had 1 pox in the mouth and a fever of 100F, headache (early morning) and one sore in the oral cavity. No other details. Unspecified medical attention was sought. the outcome was reported as recovered. There was no product quality complaint. Additional information has been requested.
Age: 7.0
Sex: F
Vaccine: VARCEL
Symptoms: Injection site induration
Clinical narrative: Information has been received from a physician concerning a 7-year-old female with no pertinent medical history or drug reactions/allergies, who on 25-Mar-2008 at approximately 15:00 was vaccinated subcutaneous in the right arm with a second dose of VARIVAX (Merck) (lot# 659943/1800U). There was no concomitant medications or no illness at the time of the vaccination. On 26-Mar-2008 the patient developed lemon size knot at the injection site after receiving a dose of the vaccine. There were no lab diagnostic studies performed. Unspecified medical attention was sought. On an unspecified date the patient recovered. There was no product quality complaint. Additional information is not expected.
Age: 1.1
Sex: M
Vaccine: VARCEL
Symptoms: Blister, Varicella, Varicella post vaccine
Clinical narrative: Information has been received from a registered nurse concerning a 32 month old who on 25-AUG-2006 was vaccinated with 0.5 ml of VARIVAX (Merck) (Lot # 652667/1035R). On 30-MAR-2008 the patient developed a chicken pox rash and vesicles, with over 100 lesions. It was noted that the clinic was contacted, but it was unspecified if medical attention was sought. There was no product quality complaint. At the time of reporting the patient was recovering. No further information is available.
Sex: U
Vaccine: VARCEL
Symptoms: Hypersensitivity, Urticaria
Clinical narrative: Information has been received from a physician concerning a child who was vaccinated with VARIVAX (Merck).  "In the past couple of weeks", in approximately March 2008, the patient developed hives after receiving VARIVAX (Merck).  It was reported that it was not a chicken pox rash, but rather a hypersensitivity reaction.  Unspecified medical attention was sought.   There was no product quality complaint.  At the time of reporting the patient was recovered (date unspecified).  Additional information has been requested.
Age: 70.0
Sex: F
Vaccine: VARCEL
Symptoms: Wrong drug administered
Clinical narrative: Information has been received from a physician concerning a female in her 70's who on approximately 26-FEB-2008 was vaccinated with a dose of VARIVAX (Merck) instead of ZOSTAVAX (Merck). It was noted that the patient was told by the administering local clinic "that they always give VARIVAX (Merck) as the shingles vaccine". It is unknown if medical attention was sought. There was no product quality complaint. Additional information has been requested.
Age: 11.0
Sex: M
Vaccine: VARCEL
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Information has been received from a consumer concerning her 11 year old son with a drug reaction/allergy to soy and peanut, who on 01-APR-2008 was vaccinated with a dose of VARIVAX (Merck).  On 02-APR-2008 the patient had an injection site reaction that was the size of a half-dollar.  The area was red and raised.  No further information was available from the consumer.  Unspecified medical attention was sought, spoke to nurse.  There was no product quality complaint.  Additional information has been requested.
Age: 17.0
Sex: F
Vaccine: HPV4, VARCEL
Symptoms: Mobility decreased, Myalgia
Clinical narrative: Information has been received from a physician concerning a 17 year old female with no pertinent medical history and no drug reaction / allergies, who on approximately 01-APR-2008 was vaccinated with 1 dose of VARIVAX (Merck) (lot number: 1511U). Suspect therapy that day included: a third dose of GARDASIL (lot number: /0978U). Concomitant therapy included: Ibuprofen and Seasonale. On approximately 02-Apr-2008 the patient reported having muscle pain within 48 hours of getting both vaccines. On approximately 04-Apr-2008 in the morning, the myalgia was remarkable. The patient had to slide down the stairs on her buttocks to get downstairs. There were no lab diagnostic studies performed. Unspecified medical attention was sought, the patient was seen. The outcome was reported as not recovered. There was no product quality complaint. Additional information has been requested.
Age: 10.0
Sex: F
Vaccine: VARCEL
Symptoms: C-reactive protein increased, Incorrect route of drug administration, Injection site erythema, Injection site pain, Injection site pruritus
Clinical narrative: Information has been received from a consumer concerning his 10 year old daughter who on 04-OCT-1998 was vaccinated with th first dose of VARIVAX (Merck) via intramuscular administration on her left upper arm. On 04-APR-2008 the patient developed an injection site reaction, one day after she was vaccinated with the second dose of VARIVAX (Merck) intramuscularly. The patient developed redness, swelling, itching and soreness at the injection site of the left upper arm. The size of the reaction increased and the patient was examined in the physician's office later that day. At that time, the diagnosis was "a reaction to the vaccine". No treatment was prescribed. On 05-APR-2008, the area of redness had increased in size and the patient was evaluated in the emergency room (but not admitted to the hospital). The evaluation revealed a 11 times 13cm area of redness. Blood studies were normal except for an elevated C-reactive protein. The patient was diagnosed with a bacterial infection at the injection site and was prescribed oral KEFLEX. On 07-APR-2008, the symptoms are improving. No further information is available.
Age: 10.0
Sex: F
Vaccine: VARCEL
Symptoms: Injection site swelling
Clinical narrative: Information has been received from a consumer concerning his 10 year old daughter who on 04-OCT-1998 was vaccinated with th first dose of VARIVAX (Merck) via intramuscular administration on her left upper arm. On 04-APR-2008 the patient developed an injection site reaction, one day after she was vaccinated with the second dose of VARIVAX (Merck) intramuscularly. The patient developed redness, swelling, itching and soreness at the injection site of the left upper arm. The size of the reaction increased and the patient was examined in the physician's office later that day. At that time, the diagnosis was "a reaction to the vaccine". No treatment was prescribed. On 05-APR-2008, the area of redness had increased in size and the patient was evaluated in the emergency room (but not admitted to the hospital). The evaluation revealed a 11 times 13cm area of redness. Blood studies were normal except for an elevated C-reactive protein. The patient was diagnosed with a bacterial infection at the injection site and was prescribed oral KEFLEX. On 07-APR-2008, the symptoms are improving. No further information is available.
Age: 10.0
Sex: M
Vaccine: VARCEL
Symptoms: Skin lesion
Clinical narrative: Information has been received from a registered nurse concerning her 10 year old son who on an unspecified date was vaccinated with the first dose of VARIVAX (Merck). The nurse reported that the her son developed 4-5 lesions after the first dose of VARIVAX was given. On 21-MAR-2008, her son was vaccinated with the second dose VARIVAX (Merck) (Lot#659000/1491U) subcutaneously. The nurse reported that her son on 28-MAR-2008 developed approximately 2 lesions after receiving VARIVAX; on 29-MAR-2008 he developed 5-6 lesions and on 30-MAR-2008 he developed 2-3 lesions. The lesions had a duration of approximately 7-8 days. At the time of the report the patient had recovered. Additional information is not expected.
Age: 7.0
Sex: M
Vaccine: VARCEL
Symptoms: Pruritus, Varicella, Varicella post vaccine
Clinical narrative: Information has been received from a registered nurse concerning an 8 year old male who on 03-Nov-2000 was vaccinated with the first dose of VARIVAX (Merck), and on 05-Feb-2007 was vaccinated with the second dose of 0.5ml of VARIVAX (Merck) (lot# 653517/1300F). The registered nurse reported that on 08-Apr-2008 the patient experienced a chickenpox rash on his chest, abdominal area and back. It was noted that the patient was afebrile and had fewer than 50 lesions. The patient was prescribed ZYRTEC to help with the itching. The patient had not recovered from the chickenpox rash on his chest, abdominal area and back. There was no product quality complaint. No further information is available.
Sex: U
Vaccine: VARCEL
Symptoms: Medication error, Wrong drug administered
Clinical narrative: Information has been received from a registered nurse concerning a patient who on approximately 01-APR-2008 was vaccinated with a dose of VARIVAX (Merck) instead of ZOSTAVAX (Merck). Not a PQC, human error noted. No additional information was available. There was no product quality complaint. Additional information has been requested.
Age: 4.0
Sex: M
Vaccine: VARCEL
Symptoms: Immediate post-injection reaction, Urticaria
Clinical narrative: Information has been received from a nurse concerning a 4 to 6 year old male who on approximately 01-APR-2008 was vaccinated with VARIVAX (Merck). Concomitant therapy included other unspecified vaccines given on the same day. The nurse included other unspecified vaccines given on the same day. The nurse reported that the patient who was vaccinated with second dose of VARIVAX (Merck) developed hives immediately post vaccination. The patient was observed and monitored at the office. At the time of the report the patient had recovered. Additional information has been requested.
Age: 81.0
Sex: F
Vaccine: VARCEL
Symptoms: Wrong drug administered
Clinical narrative: Information has been received from a physician concerning an 81 year old female who on 08-APR-2008 was vaccinated with "regular dose" of VARIVAX (Merck) instead of ZOSTAVAX (Merck) for prevention of shingles. This was a medical error by the medical assistant. The physician reported that the medical assistant thought VARIVAX (Merck) and ZOSTAVAX (Merck) were the same thing. The patient was not experiencing any known symptoms. It was unknown if the patient sought medical attention. Additional information has been requested.
Age: 12.0
Sex: M
Vaccine: VARCEL
Symptoms: Varicella post vaccine
Clinical narrative: Information has been received from a physician concerning a 12 year old male who on the day before the child's first birthday was vaccinated subcutaneously with a 0.5 ml dose of VARIVAX (Merck).  The physician reported that the patient experienced a break through case of chickenpox on an unspecified date (greater than 50 lesions) and the patient was already given VARIVAX.  Medical attention was sought, the patient was seen by a physician.  The physician stated this patient had a more serious case of chickenpox.  At the time of the report the patient was recovering from the adverse event.  There was no product quality complaint.  Additional information has been requested.
Age: 12.0
Sex: F
Vaccine: VARCEL
Symptoms: Pruritus, Rash, Rash papular, Varicella post vaccine
Clinical narrative: Information has been received from a physician concerning a 13 year old (previously reported as 11 year old) female with no pre-existing allergies, birth defects or medical condition and no illness at time of vaccination who on 20-FEB-1998 was vaccinated with a first dose of VARIVAX (Merck) (LOT# 623647/0802E) and on 12-OCT-2006 was vaccinated subcutaneously in left arm with a 0.5 ml second dose of VARIVAX (Merck) (LOT# 652630/0247F). On 06-APR-2008 the patient experienced a mild case of chickenpox. The rash appeared on the patient's trunk with different sizes and pruritus. It was noted that most of the lesion were papular. The patient did not have a fever. The patient treated with BENADRYL, calamine lotion and AVEENO as needed. On 16-APR-2008 the patient recovered from the events. The patient sought medical attention by having an office visit. There was no product quality complaint. Additional information is not expected.
Age: 3.0
Sex: F
Vaccine: VARCEL
Symptoms: Varicella, Varicella post vaccine
Clinical narrative: Information has been received from a physician concerning an approximately 36 month old female patient with no pertinent medical history who was vaccinated with a first dose of VARIVAX (Merck).  The physician reported that the patient experienced 2 breakthrough cases of chickenpox after being vaccinated 2 different times.  The first breakthrough occurred when the patient was about 3 years of age after the patient received the first dose of the vaccine on an unspecified date.  Sometime in 2004, the patient received her second dose and experienced the second breakthrough case, about 8 months later.  Unspecified medical attention was sought.  At the time of the report the patient had recovered.  Additional information has been requested.
Age: 7.0
Sex: M
Vaccine: VARCEL
Symptoms: Varicella post vaccine
Clinical narrative: Information has been received from a physician assistant concerning a "7 or 8 years old" male who in September 2007, was vaccinated with a second 0.5 mL dose of VARIVAX (Merck). Subsequently the patient experienced breakthrough varicella, less then 50 lesions after receiving the vaccine. No further information was provided. Unspecified medical attention was sought, patient saw the physician assistant. There was no product quality complaint. Additional information has been requested.
Age: 4.0
Sex: M
Vaccine: VARCEL
Symptoms: Pyrexia
Clinical narrative: Information has been received from a physician concerning a 4 year old male with no pertinent medical history and no drug reactions/allergies, who was vaccinated with a second 0.5 mL dose of VARIVAX (Merck). There was no concomitant medication. On approximately 25-MAR-2008 the patient after receiving the vaccine experienced a fever. No further information was provided. There were no lab diagnostic studies performed. Unspecified medical attention was sought. The outcome was reported as recovered. There was no product quality complaint. Additional information is not expected. The reporting physician is unable to identify the patient.
Age: 1.0
Sex: F
Vaccine: VARCEL
Symptoms: Rash, Rash papular, Rash vesicular
Clinical narrative: Information has been received from a health professional concerning a a 13-year-old female with a history of rhinitis allergic and scoliosis who on 02-OCT-1995 was vaccinated with a first dose of VARIVAX (Merck). There was no illness at the time of vaccination. On 01-APR-2008 the patient experienced a vesicular, papular rash on her face, trunk and back. The patient was seen by a physician. Subsequently, the patient recovered on 07-APR-2008. Additional information has been requested.
Age: 14.0
Sex: F
Vaccine: VARCEL
Symptoms: Injection site erythema, Wrong drug administered
Clinical narrative: Information has been received from a licensed practical nurse (L.P.N.) concerning a 14-year-old female, weight 179 pound, height 67.5 inch, who on 10-APR-2008 was vaccinated with a dose of VARIVAX (Merck) subcutaneously that was diluted with MENACTRA. It was reported that the pharmacy sent a MENACTRA in the plastic vial labeled as "sterile solution" instead of the diluent with the VARIVAX (Merck). On the invoice the MENACTRA was listed as the diluent. Lot numbers were not provided. On the eve of vaccination, a local reaction redness at the site was noted. The redness persisted for 2 days. Subsequently, the patient recovered. No product quality complaint was involved. Additional information is not expected.
Sex: U
Vaccine: VARCEL
Symptoms: Injection site erythema, Injection site rash, Injection site warmth
Clinical narrative: Information has been received from a registered nurse concerning a patient who was vaccinated subcutaneous with a 0.5 ml second dose of VARIVAX (Merck). Subsequently the patient experienced injection site reactions after the second dose of VARIVAX (Merck). The symptoms included redness, bumps and heat at the injection site. Within 3 - 4 days, the reaction was gone. The nurse also reported the same events for other patients (refer to WAES# 0806USA00992). Additional information has been requested.
Age: 1.2
Sex: F
Vaccine: VARCEL
Symptoms: Varicella post vaccine
Clinical narrative: Information has been received from a registered nurse concerning a 11-year-old female who on 05-JUN-1998 was vaccinated SC with a 0.5 mL dose of VARIVAX (Merck) (Lot #625047/1574E). The RN reported that on 05-APR-2008, the patient developed chickenpox. It was unknown if medical attention was sought. In April 2008, the patient's chickenpox resolved. All pertinent information given was via phone. No further information is expected.
Age: 1.1
Sex: M
Vaccine: VARCEL
Symptoms: Varicella post vaccine
Clinical narrative: Information has been received from a registered nurse concerning a 7 year old male who on 22-Jun-2001 was vaccinated with VARIVAX (Merck) (lot# 635948/1333K). 0.5ml, SC. On 23-Mar-2008 the patient developed a chicken pox outbreak after receiving VARIVAX (Merck). Subsequently, the patient recovered from a chicken pox outbreak after receiving VARIVAX. It was not reported if the patient sought medical attention. Additional information is not expected.
Sex: U
Vaccine: VARCEL
Symptoms: Blister, Rash
Clinical narrative: Information has been received from a health professional concerning a patient who on 30-NOV-2005 was vaccinated with a dose of VARIVAX (Merck) (647538/0784R) subcutaneously in the left arm. On 01-APR-2008 the patient experienced rash on torso/back and papular vesicles. No crusting yet. No illness at the time of vaccination. Additional information has been requested.
Age: 14.0
Sex: M
Vaccine: VARCEL
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Information has been received from a registered nurse concerning a 14 year old male child who "within the last two weeks" on approximately 01-APR-2008 was vaccinated SQ with 0.5ml of VARIVAX (Merck) (lot # 660057/1806U). There was no concomitant medication. Subsequently, the patient developed a severe red raised area at the injection site after receiving the vaccination. Unspecified medical attention was sought. It was unspecified if lab studies were performed. At the time of the report, the patient's status was unknown. There was no product quality complaint involved. Additional information has been requested. This is one of several reports from the same source.
Age: 9.0
Sex: F
Vaccine: VARCEL
Symptoms: Injection site erythema, Injection site lymphadenopathy, Injection site swelling
Clinical narrative: Information has been received from a registered nurse concerning a 9 year old patient with a history of premature puberty and asthma and a drug reaction/allergies that included an unknown reaction to flu vaccine, who on 09-APR-2008 was vaccinated IM with a dose of VARIVAX (Merck) (lot number:  659610/1654U).  Suspect therapy included GARDASIL.  On 10-APR-2008 the patient developed local swelling, redness and a lump under the skin at the injection site.  Recommended treatment was ice and MOTRIN.  There were no lab diagnostic studies performed.  Unspecified medical attention was sought, via phone call to the office.  The outcome was reported as recovering.  There was no product quality complaint.  Follow-up information from the reporting medical assistant (also reported as registered nurse) indicated that the 9 year old female who on 09-APR-2008 at 12:00 was vaccinated IM with her second dose of VARIVAX (Merck) (lot# 659610/1654U).  After vaccination the patient developed redness and swelling.  Additional information has been requested.
Age: 1.0
Sex: M
Vaccine: VARCEL
Symptoms: Otitis media, Rash vesicular, Scab, Tympanic membrane disorder, Varicella post vaccine
Clinical narrative: Information has been received from a physician concerning a 4 year old male patient, who on 24-Feb-2005, was vaccinated with VARIVAX (Merck) (LOT #648318/0440P) in his left arm SC. Subsequently, his parent called office reporting rash on back and chest which were defined as pimples with raised center. On 04-APR-2008, the patient was seen in office. It was reported that he broke out in a rash prior to starting antibiotics yesterday (03-APR-2008) for otitis media. The physician stated that tympanic membranes were thick and dull. He had about 12 lesions which would be best described as a vesicular rash in various stages of eruption and scabbing. The physician reported that he certainly quality for chicken pox. He was diagnosed as post vaccine chicken pox. The physician told the parents he would probably only break out for about 3 days with less than 50 lesions. He would only be mildly ill. The patient was to continue to ZITHROMAX for his otitis media. The physician also wrote a note for him to return to daycare on 07-APR-2008. Subsequently, the patient recovered. Additional information is not expected.